Skip to main content
. 2022 Sep 26;2022:4457696. doi: 10.1155/2022/4457696

Table 2.

Efficacy analysis of STER in the treatment of submucosal masses in esophageal muscularis propria [cases (%)].

Groups Cases Complete remission Partial remission Stability Deterioration Effective rate
The STER group 136 56 (41.18) 70 (51.47) 8 (5.88) 2 (1.47) 134 (98.53)
The ESD group 136 49 (36.03) 59 (43.38) 13 (9.56) 15 (11.03) 121 (88.97)
χ 2 0.760 1.784 1.290 10.604 10.604
P 0.383 0.182 0.256 0.001 0.001